The perceived development needs for medicines information services in university hospital pharmacies: A mixed methods study.
Interview
Medicines information center
Medicines information services
Multiprofessional collaboration
Network
Survey
Journal
Exploratory research in clinical and social pharmacy
ISSN: 2667-2766
Titre abrégé: Explor Res Clin Soc Pharm
Pays: United States
ID NLM: 9918266300706676
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
24
11
2021
revised:
10
03
2022
accepted:
21
04
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
17
5
2022
Statut:
epublish
Résumé
Reliable and evidence-based medicines information (MI) is critical for patient care. To guarantee this, in many countries, there are medicines information centers (MICs) which offer medicines information services (MISs). While there are no MICs in Finland, pharmacists in all five university hospital pharmacies provide MISs. A proposal for establishing five MICs has been made by the National Medicines Information Network. The aim was to explore the current MISs and the perceptions of current and potential MI service providers of the need for the proposed national MICs. Barriers and facilitators for potential transition from the current MISs provided by the university hospital pharmacies to establishing national MICs, were examined. This sequential explanatory mixed methods study was conducted nationally during September 2019-April 2020 as an online survey and semi-structured individual, pair and group theme interviews with hospital representatives. The survey questionnaire was sent to chief pharmacists and MI pharmacists in all five Finnish university hospital pharmacies ( All invited representatives participated in the study. Offered MISs are quite similar but the human resources vary among the organizations. Answering MI questions was one of the core MISs. Most representatives considered a proposal of establishing five MICs to Finland positively. The expected benefits were related to achieving an official status to enhance MI, establishing the MICs within the university hospitals and close to where the MISs are needed, and fostering multiprofessional collaboration and collaboration between the MICs. Limited financial and human resources were seen the most critical challenges. The existing expertise of the pharmacists and the similarities in MISs provided by the university hospital pharmacies seem to provide a good basis and preconditions for expanding MI operations and forming MICs at the national level. By pooling current limited resources, synergies could be achieved and MISs, and potentially MICs developed. The establishment of MICs may enhance utilization of networking and multiprofessional collaboration in producing MISs at the national level.
Sections du résumé
Background
UNASSIGNED
Reliable and evidence-based medicines information (MI) is critical for patient care. To guarantee this, in many countries, there are medicines information centers (MICs) which offer medicines information services (MISs). While there are no MICs in Finland, pharmacists in all five university hospital pharmacies provide MISs. A proposal for establishing five MICs has been made by the National Medicines Information Network.
Objectives
UNASSIGNED
The aim was to explore the current MISs and the perceptions of current and potential MI service providers of the need for the proposed national MICs. Barriers and facilitators for potential transition from the current MISs provided by the university hospital pharmacies to establishing national MICs, were examined.
Methods
UNASSIGNED
This sequential explanatory mixed methods study was conducted nationally during September 2019-April 2020 as an online survey and semi-structured individual, pair and group theme interviews with hospital representatives. The survey questionnaire was sent to chief pharmacists and MI pharmacists in all five Finnish university hospital pharmacies (
Results
UNASSIGNED
All invited representatives participated in the study. Offered MISs are quite similar but the human resources vary among the organizations. Answering MI questions was one of the core MISs. Most representatives considered a proposal of establishing five MICs to Finland positively. The expected benefits were related to achieving an official status to enhance MI, establishing the MICs within the university hospitals and close to where the MISs are needed, and fostering multiprofessional collaboration and collaboration between the MICs. Limited financial and human resources were seen the most critical challenges.
Conclusion
UNASSIGNED
The existing expertise of the pharmacists and the similarities in MISs provided by the university hospital pharmacies seem to provide a good basis and preconditions for expanding MI operations and forming MICs at the national level. By pooling current limited resources, synergies could be achieved and MISs, and potentially MICs developed. The establishment of MICs may enhance utilization of networking and multiprofessional collaboration in producing MISs at the national level.
Identifiants
pubmed: 35573485
doi: 10.1016/j.rcsop.2022.100140
pii: S2667-2766(22)00039-7
pmc: PMC9096662
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100140Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
All authors are members of the National Medicines Information Network. One of the authors participated in the interviews in her role as an MI pharmacist.
Références
Eur J Clin Pharmacol. 2008 Aug;64(8):769-74
pubmed: 18512053
Am J Health Syst Pharm. 2009 Oct 1;66(19):1718-22
pubmed: 19767377
BMC Clin Pharmacol. 2010 Dec 02;10:16
pubmed: 21122160
Am J Health Syst Pharm. 2015 Apr 1;72(7):573-7
pubmed: 25788512
Eur J Clin Pharmacol. 2014 Nov;70(11):1395-401
pubmed: 25213372
Curr Pharm Teach Learn. 2018 May;10(5):579-583
pubmed: 29986817
Res Social Adm Pharm. 2008 Jun;4(2):144-52
pubmed: 18555967
BMJ Open. 2012 Mar 15;2(2):e000642
pubmed: 22422916
J Eval Clin Pract. 2015 Apr;21(2):307-12
pubmed: 25644896
Health Policy. 2013 Jul;111(2):200-5
pubmed: 23683473
Clin Ther. 2016 Feb;38(2):414-21
pubmed: 26831829
Am J Health Syst Pharm. 2005 Dec 1;62(23):2511-4
pubmed: 16303908
Eur J Clin Pharmacol. 2013 May;69 Suppl 1:65-72
pubmed: 23640190
Int J Pharm Pract. 2010 Dec;18(6):353-61
pubmed: 21054596
Basic Clin Pharmacol Toxicol. 2016 Dec;119(6):523-532
pubmed: 27685872
J Hum Lact. 1996 Sep;12(3):239-42
pubmed: 9025433
Am J Health Syst Pharm. 2020 Jan 1;77(1):33-38
pubmed: 31743390
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Am J Health Syst Pharm. 2004 Oct 1;61(19):2023-32
pubmed: 15509125
Am J Health Syst Pharm. 1996 Aug 1;53(15):1843-5
pubmed: 8842315
Hosp Pharm. 2017 Jul;52(7):452-453
pubmed: 29276270
J Clin Pharm Ther. 2019 Jun;44(3):489-492
pubmed: 30710370
Eur J Clin Pharmacol. 2018 Jun;74(6):843-851
pubmed: 29487959